tiprankstipranks
Sinopharm Group Co Ltd Class H (HK:1099)
:1099
Hong Kong Market
1099
Sinopharm Group Co
RESEARCH TOOLSreports
Want to see HK:1099 full AI Analyst Report?

Sinopharm Group Co (1099) Ratios

10 Followers

Sinopharm Group Co Ratios

HK:1099's free cash flow for Q4 2025 was ¥0.07. For the 2025 fiscal year, HK:1099's free cash flow was decreased by ¥ and operating cash flow was ¥0.03. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.41 1.41 1.39 1.39 1.36
Quick Ratio
 1.15 1.15 1.14 1.15 1.10
Cash Ratio
 0.25 0.25 0.22 0.26 0.24
Solvency Ratio
 0.04 0.04 0.04 0.05 0.05
Operating Cash Flow Ratio
 0.05 0.06 0.05 0.07 0.09
Short-Term Operating Cash Flow Coverage
 0.12 0.22 0.18 0.31 0.40
Net Current Asset Value
¥ 90.63B¥ 90.63B¥ 81.30B¥ 73.76B¥ 64.70B
Leverage Ratios
Debt-to-Assets Ratio
 0.28 0.28 0.19 0.19 0.19
Debt-to-Equity Ratio
 1.29 1.29 0.97 0.99 1.02
Debt-to-Capital Ratio
 0.56 0.56 0.49 0.50 0.51
Long-Term Debt-to-Capital Ratio
 0.04 0.04 0.10 0.16 0.15
Financial Leverage Ratio
 4.65 4.65 4.98 5.14 5.36
Debt Service Coverage Ratio
 0.16 0.25 0.25 0.39 0.39
Interest Coverage Ratio
 9.64 6.68 5.92 6.84 5.85
Debt to Market Cap
 2.08 1.23 1.14 1.20 1.18
Interest Debt Per Share
 35.35 35.59 25.35 24.59 23.43
Net Debt to EBITDA
 2.24 2.30 1.09 0.37 0.55
Profitability Margins
Gross Profit Margin
7.28%7.17%7.57%8.13%8.59%
EBIT Margin
2.94%2.90%3.05%3.77%4.00%
EBITDA Margin
3.69%3.64%3.45%4.51%4.75%
Operating Profit Margin
2.84%2.90%2.77%3.39%3.73%
Pretax Profit Margin
2.57%2.57%2.40%3.27%3.36%
Net Profit Margin
1.24%1.24%1.21%1.52%1.54%
Continuous Operations Profit Margin
1.88%1.88%1.78%2.52%2.60%
Net Income Per EBT
48.33%48.35%50.35%46.40%45.93%
EBT Per EBIT
90.48%88.80%86.49%96.55%90.10%
Return on Assets (ROA)
1.81%1.78%1.79%2.36%2.34%
Return on Equity (ROE)
8.62%8.30%8.94%12.14%12.53%
Return on Capital Employed (ROCE)
11.28%11.30%11.36%14.24%15.87%
Return on Invested Capital (ROIC)
4.82%5.70%5.82%7.83%8.63%
Return on Tangible Assets
1.86%1.83%1.85%2.42%2.42%
Earnings Yield
13.86%12.79%11.29%15.85%15.59%
Efficiency Ratios
Receivables Turnover
 2.76 2.71 2.83 3.21 3.23
Payables Turnover
 4.69 4.62 3.44 3.54 3.49
Inventory Turnover
 8.35 8.21 8.66 9.13 8.28
Fixed Asset Turnover
 31.28 30.72 29.77 29.98 31.03
Asset Turnover
 1.46 1.43 1.49 1.56 1.51
Working Capital Turnover Ratio
 5.87 5.68 6.08 6.64 7.08
Cash Conversion Cycle
 98.27 100.08 65.23 50.59 52.65
Days of Sales Outstanding
 132.31 134.68 129.09 113.67 113.18
Days of Inventory Outstanding
 43.74 44.47 42.13 39.98 44.06
Days of Payables Outstanding
 77.77 79.07 105.98 103.06 104.58
Operating Cycle
 176.04 179.15 171.21 153.65 157.24
Cash Flow Ratios
Operating Cash Flow Per Share
 3.86 4.53 3.70 5.50 6.72
Free Cash Flow Per Share
 3.36 4.01 3.07 4.75 5.94
CapEx Per Share
 0.50 0.52 0.63 0.75 0.77
Free Cash Flow to Operating Cash Flow
 0.87 0.89 0.83 0.86 0.88
Dividend Paid and CapEx Coverage Ratio
 2.09 3.78 2.47 3.51 4.41
Capital Expenditure Coverage Ratio
 7.78 8.74 5.87 7.35 8.67
Operating Cash Flow Coverage Ratio
 0.11 0.13 0.15 0.23 0.30
Operating Cash Flow to Sales Ratio
 0.02 0.03 0.02 0.03 0.04
Free Cash Flow Yield
20.55%22.98%15.34%25.98%33.92%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 7.21 7.82 8.86 6.31 6.41
Price-to-Sales (P/S) Ratio
 0.09 0.10 0.11 0.10 0.10
Price-to-Book (P/B) Ratio
 0.61 0.65 0.79 0.77 0.80
Price-to-Free Cash Flow (P/FCF) Ratio
 4.87 4.35 6.52 3.85 2.95
Price-to-Operating Cash Flow Ratio
 4.24 3.85 5.41 3.33 2.61
Price-to-Earnings Growth (PEG) Ratio
 16.30 -8.83 -0.40 1.01 0.67
Price-to-Fair Value
 0.61 0.65 0.79 0.77 0.80
Enterprise Value Multiple
 4.67 4.97 4.19 2.49 2.63
Enterprise Value
 98.15B 101.53B 84.50B 67.09B 69.04B
EV to EBITDA
 4.67 4.97 4.19 2.49 2.63
EV to Sales
 0.17 0.18 0.14 0.11 0.13
EV to Free Cash Flow
 9.35 8.11 8.82 4.52 3.72
EV to Operating Cash Flow
 8.14 7.18 7.32 3.91 3.29
Tangible Book Value Per Share
 39.76 39.76 37.73 35.35 31.42
Shareholders’ Equity Per Share
 26.91 26.92 25.28 23.90 21.81
Tax and Other Ratios
Effective Tax Rate
 0.27 0.27 0.26 0.23 0.23
Revenue Per Share
 182.77 179.55 187.31 191.17 176.93
Net Income Per Share
 2.27 2.23 2.26 2.90 2.73
Tax Burden
 0.48 0.48 0.50 0.46 0.46
Interest Burden
 0.87 0.89 0.79 0.87 0.84
Research & Development to Revenue
 <0.01 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.04 0.04 0.04 0.01 0.01
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 1.70 0.96 0.82 0.88 1.13
Currency in CNY